📌 Key Takeaways
- Topic: Silica Exposure Limits: OSHA, ACGIH and EU Limits Compared
- Keywords: silicon oxide
- Published: 2026-11-20 09:33:07
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is the Boiling Point of Silica (SiO₂)? Thermal Properties Explained
- Best Silica Supplier: How to Choose in 2026 (Checklist and Comparison Criteria)
- Silica as a Rheology Modifier: How It Controls Viscosity and Flow
- Singh, A. P., Biswas, A., Shukla, A. & Maiti, P. Targeted therapy in chronic diseases utilizing nanomaterial-based drug delivery vehicles. Signal Transduct. Target Ther. 4, 33 (2019). Post PubMed Central PubMed Google Scholar
- Crystalline Silica Powder: Grades, Uses and Safe Handling Requirements
- Zhao, Y. & Zhu, Y. Synergistic cytotoxicity of low-energy ultrasound and innovative mesoporous silica-based sensitive nanoagents. J. Mater. Sci. 49, 3665-3673 (2014). Piece CAS Google Scholar
- Silica for Coatings: Types, Functions and How to Choose the Right Grade
- Zou, R. et al. 68 Ga-labeled magnetic-NIR persistent luminescent hybrid mesoporous nanoparticles for multimodal imaging-guided chemotherapy and photodynamic therapy. ACS Appl. Mater. Interfac. 13, 9667-9680 (2021). Post CAS Google Scholar
Silica Flatting Agent: Gloss Reduction Mechanism, Grades and Applications
What is silica (SiO₂)?
hydrated silica
What is the difference between fumed silica and precipitated silica?
silica for wafer polishing
What drives silica raw material prices?
silica flatting agent Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.